We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Bioseek | LSE:ATD | London | Ordinary Share | GB0009231639 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.50 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
06/6/2011 05:49 | I say 'perfect' to describe the above trade and rightly so. With this system the set-ups are few and far between. Some are still not that apparent until the benefit of hindsight. Is it trending up? down? Is that last peak a HH or should i count the one before etc etc... its the element of doubt that will lose you money, or at least stop you from placing a heavy trade. In the above chart we have several factors. Trend hasn't changed as yet, so carry on looking for the indicators to give a buy signal on the long side. Add to that a nice flag pattern. Then add the line that clearly gave a little resistance/small backtest on the way up. This line is now acting as support. Wish i could find one of these everyday! | and then | |
03/6/2011 10:13 | Let me guess spaceparallax LOL ! By the way the FT shows today the last trade was a sell | buywell2 | |
03/6/2011 10:12 | I have been reading the debate on Asterand's prospects. It seems rather one-sided with many factual contributions from those who are worried, versus empty platitudes and rudeness from space parallax. I do not often post but think a riddle might be in order. Question: How can you make a small fortune with ATD? Answer: Start with a large one. Contributed tongue in cheek of course | david123456 | |
02/6/2011 08:19 | Down again this morning I see, though to be fair the markets are in a bit of a state due to US data Pharmas though usually are seen as a 'safe heaven' in times of trouble , and are one of the best performing sectors 10p support could soon be tested if the downtrend continues. dyor | buywell2 | |
01/6/2011 19:09 | >>spaceparallax I obviously have the published data but I was particularly interested in hearing the details of your take on things. Since you dont appear keen to join in adult debate I will sign off now and leave you to your ivory tower. best of luck and bye, bye, pim | petersinthemarket | |
01/6/2011 14:20 | When it drops as fast as that, its not feasible to re-enter the trade. PA can whipsaw even if only to drop again. The reason for banking the points quickly on this occasion was a valid one. In hindsight it was better to have risked seeing the 13 point gain disappear to hold out for the 25 target, but of course with the benefit of hindsight i would have put £1000 on Durlacher shares when they were a penny and sold them when they hit £10 back in 1999! | and then | |
01/6/2011 13:47 | PIM, The only numbers I rely on are the Company fundamentals, business plan and perhaps broker views (although those can be misleading). Everything else is froth. I presume you know where to find that data - assuming it's of interest? It's nice to hear that you are able to chuckle - do be careful not to breathe in too much water whilst submerged. | spaceparallax | |
01/6/2011 11:54 | >>spaceparallax-you made me chuckle - you cannot honestly believe that the market would take any notice of a couple of posters with doubts! If I really could move markets on this thread I would become unstoppable! And if doubters stop posting here there will only be you left in your ivory tower - a bit lonely methinks. I am still in, I am underwater, I intend to stay in, I hope to see some improvement but I repeat I am a bit sceptical about the short term. I asked you politely to give us your reasons for support. I would welcome some encouragement. Perhaps you would be kind enough to give us some numbers. regards, pim | petersinthemarket | |
01/6/2011 09:20 | there you go again | curious | |
01/6/2011 08:35 | I find it bizarre that posters who feel the way you do actually claim to hold. You're either lying about holding or are complete plonkers for doing so despite your 'better judgement'. I hold because I see value in this share and am happy with the fundamentals and business plan. Whilst I find it mildly irritating that parasites such as you are allowed to TRY to influence the mkt, it is a product of our democratic society and I must content myself with the opportunities that it sometimes avails me to top-up on the cheap. | spaceparallax | |
01/6/2011 07:53 | This sort of response to anything negative about stocks seems to be prevalant on advfn. I can't understand it myself , as saving investors from losing money is as good as advising them of shares that make money , just the other side of the coin .... it's all about preserving capital. Charts are one of the tools I use to determine what represents a good company to invest in. I have looked at ATD quite a few times over the years but each time have been put off. Since feb of this year the share is once again in downtrend mode .... I don't like going against the trend and for now a move to 10p again looks more likely than a rise. Re long term investing in ATD I suggest you look at the medium and long term TA predictions I also use TA with charts plus fundementals to base my investment decisions on eg there has been some bearish Xovers of moving averages recently dyor spaceparallax - 31 May'11 - 13:43 - 442 of 446 given that you guys are so downbeat, I trust that you'll be clearing out and will have no further interest here - unless of course you have sinister motives for hanging around. On the DS downgrade, I can't question what they've said. However, I do disagree with the thinking that yielded the downgrade. Whilst there is sound reasoning in the pressures on preclinical trialing expenditure, that can lead to both a reduction in available business or as is increasingly becoming the case more intelligent expenditure. That's where ATD and Bioseek step-in - they offer more effective targeting of testing based upon their bank of human tissue samples and accompanying knowledge. As with all businesses out there, the pressures of the current economic climate are significant; however, ATD are well placed to thrive from the big pharma moves to cut costs largely through slashing in-house work and selecting more cost effective external solutions. Obviously, we choose to read the situation differently. I'm in for the long haul and see myself doing very nicely. | buywell2 | |
01/6/2011 07:14 | spaceparallex You talk from two sides of your mouth. I am a holder and,like Peter, under water from my entry price and worried about prospects for the future. My comments have been anything but emotional. They are quite factual and objective and evidence-based. It is plain to see that you do not like them but can not argue with them so you denigrate the contributor When someone criticises the messenger instead of the message, it is generally a sign that they have lost the argument. So far, you are the one who is emotional and who ramps. I agree with Peter. Give us objective evidence to support your view that ATD will do well in the future. Stop the nonsense about how happy you are to acquire more shares as the price drops and drops and drops. Let us have a new pattern on this website and make it into a useful tool for everyone - including worried holders like me and Peter. Let's have an objective debate about prospects for the future without sneering comments to anyone who disagrees with the poster's view. How about starting with your OBJECTIVE reasons for believing that ATD will prosper. | curious | |
31/5/2011 22:47 | I'd love to see the pics you don't show !!! :)) | swingitbaby | |
31/5/2011 19:33 | Peter, The main reasons are that I want to grow my savings and see the ATD business model as offering a pretty safe way forward, even in these difficult times. I've been in for several months now and see no fundamental reasons to alter my beliefs - as an investor, I'm happy to share my views and am not averse to objective, evidence based, comments. I am always highly suspicious about people going to the trouble of posting subjective, totally negative comments - unlike an investor, these people are likely to have only one motive i.e. to force the share price down to meet their own short or because their employer has instructed them to 'bash' a share. If I feel a share isn't worth investing in, I simply don't bother posting. | spaceparallax | |
31/5/2011 18:56 | >>spaceparallax - As a holder (even though rather sceptical about making any early profits)I have a vested interest in atd doing well, but I do like to see rational arguments from both sides of the fence and I think the negative posters here have usually had good points to make. If I may say so, you seem to me to be a bit overtouchy about those on the negative side. To even things up a bit would you be kind enough to repeat the reasons you are in. Sorry if you've done this before - I hate wading back through lots of stuff. good luck to all. | petersinthemarket | |
31/5/2011 18:43 | "Share tipster 'Watshot' - part of t1ps.com Ltd pointed out that Asterand (LON:ATD) is trading at year-lows despite the fact that the company is on the verge of sustainable profitability. It said that a recent interim management statement confirmed that trading has been in line with expectations and Asterand is confident that revenue growth will continue well into the future." | aim_trader | |
31/5/2011 12:43 | given that you guys are so downbeat, I trust that you'll be clearing out and will have no further interest here - unless of course you have sinister motives for hanging around. On the DS downgrade, I can't question what they've said. However, I do disagree with the thinking that yielded the downgrade. Whilst there is sound reasoning in the pressures on preclinical trialing expenditure, that can lead to both a reduction in available business or as is increasingly becoming the case more intelligent expenditure. That's where ATD and Bioseek step-in - they offer more effective targeting of testing based upon their bank of human tissue samples and accompanying knowledge. As with all businesses out there, the pressures of the current economic climate are significant; however, ATD are well placed to thrive from the big pharma moves to cut costs largely through slashing in-house work and selecting more cost effective external solutions. Obviously, we choose to read the situation differently. I'm in for the long haul and see myself doing very nicely. | spaceparallax | |
31/5/2011 11:54 | Thanks Buywell. So it looks like he did not buy them after all. Not much of a positive signal then. | curious | |
31/5/2011 11:27 | Daniel and Stewart said The company continues to face significant headwinds from an industry in transition-contract research organisations world-wide are experiencing softer market demand in preclinical services, as pharmaceutical clients reprioritise their drug development pipelines and restructure their operations. As a result, we are downgrading our revenue forecasts by 18% in 2010 and 21% in 2011, resulting in: - FY-12/2010 Sales of £13.2m (£16.0m), PBT DS&C of -£0.9m (£0.7m) and EPS DS&C of -0.6p (0.5p). - FY-12/2011 Sales of £15.1m (£19.2m), PBT DS&C of £0.0m (£1.7m) and EPS DS&C of 0.0p (0.8p). re the FD same day as above | buywell2 | |
31/5/2011 11:18 | Strangely enough, most objective investors would see an FD buy as just about the most positive signal. You're basing your views upon selective info and twisting things to suit what is clearly a shorters/bashers agenda. Little of your postings take an objective look at the facts - presumably because that does not suit your aim. | spaceparallax |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions